Assessing the Attitudes, Knowledge, and Awareness of HIV Vaccine Research Among Adults in the United States
- 15 December 2005
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 40 (5) , 617-624
- https://doi.org/10.1097/01.qai.0000174655.63653.38
Abstract
Objectives: To assess HIV vaccine research attitudes, awareness, and knowledge among adults in the general US population, African Americans, Hispanics, and men who have sex with men (MSM). Methods: Applying results of focus groups and a media content analysis, a survey was designed and conducted to validate key HIV vaccine research themes and messages identified by focus groups and a media content analysis. Between December 2002 and February 2003, 3509 telephone interviews were conducted, including 2008 randomly selected from the general population, and 501 population-specific samples of African Americans and Hispanics, and 500 from MSM. Results: Although the majority of each population believes that an HIV preventive vaccine is the best way to control and end the global AIDS epidemic, only 34.9% of African Americans and 28.8% of the general population are supportive of someone they know volunteering for an HIV vaccine trial. The study also found that 47.1% of African Americans, 26.5% of Hispanics, and 13.4% of MSM believed an HIV vaccine already exists and is being kept secret, and 78.0% of African Americans, 57.5% of Hispanics, and 68.0% of MSM did not know or incorrectly believed that the vaccines being tested could cause HIV infection. A subanalysis of the general population also found that women generally had less knowledge of or a decreased awareness about HIV vaccine research. Conclusions: Awareness, knowledge, and attitudes toward HIV vaccine research vary by population and these issues must be addressed to ensure an adequate number of volunteers for future domestic HIV preventive vaccine clinical trials. In some populations, barriers such as misinformation and distrust must be targeted to increase support for HIV vaccine research.Keywords
This publication has 10 references indexed in Scilit:
- Recruitment and Baseline Epidemiologic Profile of Participants in the First Phase 3 HIV Vaccine Efficacy TrialJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Determinants of Enrollment in a Preventive HIV Vaccine TrialJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Caregivers' Attitudes Toward Their Family Members' Participation in Alzheimer Disease Research: Implications for Recruitment and RetentionAlzheimer Disease & Associated Disorders, 2001
- Willingness to Volunteer in Future Preventive HIV Vaccine Trials: Issues and Perspectives From Three U.S. CommunitiesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Willingness to Volunteer in Future Preventive HIV Vaccine Trials: Issues and Perspectives From Three U.S. CommunitiesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Participation of Minorities in Cancer ResearchAnnals of Epidemiology, 2000
- Factors Related to the Willingness of Young Gay Men to Participate in Preventive HIV Vaccine TrialsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United StatesAIDS, 1998
- Theory and Method in Health Audience SegmentationJournal of Health Communication, 1996
- Health Lifestyles: Audience Segmentation Analysis for Public Health InterventionsHealth Education Quarterly, 1991